Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

Clinical trial NCT02178436 · COMPLETED

Trial details

NCT number: NCT02178436
Sponsor: Mohammed Najeeb Al Hallak
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarcinoma of the Pancreas Stage IV Pancreatic Cancer

Start date: 2014-10-31
Primary completion: 2021-11-27
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.